Gossamer Bio Inc (GOSS)
0.8861
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 11:30
Gossamer Bio Max Drawdown (5Y): 98.21% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.21% |
| September 30, 2024 | 98.21% |
| August 31, 2024 | 98.21% |
| July 31, 2024 | 98.21% |
| June 30, 2024 | 98.21% |
| May 31, 2024 | 98.21% |
| April 30, 2024 | 98.21% |
| March 31, 2024 | 98.21% |
| February 29, 2024 | 98.21% |
| January 31, 2024 | 98.21% |
| December 31, 2023 | 98.21% |
| November 30, 2023 | 98.21% |
| October 31, 2023 | 98.21% |
| September 30, 2023 | 97.10% |
| August 31, 2023 | 96.41% |
| July 31, 2023 | 96.41% |
| June 30, 2023 | 96.41% |
| May 31, 2023 | 96.41% |
| April 30, 2023 | 96.41% |
| March 31, 2023 | 96.41% |
| February 28, 2023 | 93.54% |
| January 31, 2023 | 93.50% |
| December 31, 2022 | 93.50% |
| November 30, 2022 | 77.72% |
| October 31, 2022 | 77.72% |
| Date | Value |
|---|---|
| September 30, 2022 | 77.72% |
| August 31, 2022 | 77.72% |
| July 31, 2022 | 77.72% |
| June 30, 2022 | 77.72% |
| May 31, 2022 | 76.07% |
| April 30, 2022 | 74.21% |
| March 31, 2022 | 72.94% |
| February 28, 2022 | 72.94% |
| January 31, 2022 | 72.94% |
| December 31, 2021 | 72.94% |
| November 30, 2021 | 72.94% |
| October 31, 2021 | 72.94% |
| September 30, 2021 | 72.94% |
| August 31, 2021 | 72.94% |
| July 31, 2021 | 72.94% |
| June 30, 2021 | 70.14% |
| May 31, 2021 | 70.14% |
| April 30, 2021 | 70.14% |
| March 31, 2021 | 70.14% |
| February 28, 2021 | 70.14% |
| January 31, 2021 | 70.14% |
| December 31, 2020 | 70.14% |
| November 30, 2020 | 70.14% |
| October 31, 2020 | 70.14% |
| September 30, 2020 | 70.14% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
38.15%
Minimum
Nov 2019
98.21%
Maximum
Oct 2023
80.20%
Average
75.14%
Median
Max Drawdown (5Y) Benchmarks
| Bioxytran Inc | 99.99% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -74.45 |
| Beta (5Y) | 1.96 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.34% |
| Historical Sharpe Ratio (5Y) | -0.5102 |
| Historical Sortino (5Y) | -0.8905 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.03% |